Latest MedImmune Stories
SAN DIEGO, May 10, 2011 /PRNewswire/ -- Pfenex Inc., an industry leader in protein expression through the Pfenex Expression Technology(TM) platform, announced today a three year strategic collaboration with MedImmune LLC, the global biologics business of AstraZeneca.
ROCKVILLE, Md., May 9, 2011 /PRNewswire/ -- Novavax, Inc.
SOUTH SAN FRANCISCO, Calif., May 3, 2011 /PRNewswire/ -- Rigel Pharmaceuticals, Inc.
GAITHERSBURG, Md., May 1, 2011 /PRNewswire/ -- MedImmune announced today it will present 11 abstracts at the Pediatric Academic Societies (PAS) Meeting at the Colorado Convention Center in Denver, CO, April 30 - May 3, 2011.
A study of H1N1 and seasonal influenza vaccination in a sample of black and Hispanic children in Atlanta found a low rate of vaccine acceptance among parents and caregivers.
SUNNYVALE, Calif., April 26, 2011 /PRNewswire/ -- Cepheid (NASDAQ: CPHD) today announced it has received clearance from the U.S. Food & Drug Administration (FDA) to market XpertÂ® Flu.
ROCKVILLE, Md., April 19, 2011 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) announced today that Stanley C. Erck, its former Executive Chairman, has been appointed to the position of President and Chief Executive Officer and will remain as a member of the Board of Directors.
QUEBEC CITY, QC, March 30 /PRNewswire-FirstCall/ - Â Medicago Inc.
WASHINGTON, March 29, 2011 /PRNewswire/ -- MedImmune announced today it will present a total of 11 abstracts at the 45th National Immunization Conference (NIC) at the Washington Hilton in Washington, DC, March 28 - 31, 2011.
-The Company launches the clinical development of its seasonal flu vaccine- QUEBEC CITY, March 21 /PRNewswire-FirstCall/ - Medicago Inc.
- Large; stout; burly.